<?xml version="1.0"?>
<!DOCTYPE rdf:RDF [
    <!ENTITY owl "http://www.w3.org/2002/07/owl#" >
    <!ENTITY obo "http://purl.obolibrary.org/obo/" >
    <!ENTITY dc "http://purl.org/dc/elements/1.1/" >
    <!ENTITY xsd "http://www.w3.org/2001/XMLSchema#" >
    <!ENTITY bao "http://www.bioassayontology.org/bao#" >
    <!ENTITY rdfs "http://www.w3.org/2000/01/rdf-schema#" >
    <!ENTITY rdf "http://www.w3.org/1999/02/22-rdf-syntax-ns#" >
    <!ENTITY oboInOwl "http://www.geneontology.org/formats/oboInOwl#" >
]>
<rdf:RDF xmlns="http://www.bioassayontology.org/bao/bao_vocabulary_result.owl#"
     xml:base="http://www.bioassayontology.org/bao/bao_vocabulary_result.owl"
     xmlns:core="http://purl.obolibrary.org/obo/uberon/core#"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#"
     xmlns:xml="http://www.w3.org/XML/1998/namespace"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:obo="http://purl.obolibrary.org/obo/"
     xmlns:foaf="http://xmlns.com/foaf/0.1/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:efo="http://www.ebi.ac.uk/efo/"
	 xmlns:bao="http://www.bioassayontology.org/bao/#">
    <owl:Ontology rdf:about="http://www.bioassayontology.org/bao/bao_vocabulary_result.owl">
        <owl:versionIRI rdf:resource="http://www.bioassayontology.org/bao/bao_vocabulary_result.owl"/>
        <rdfs:label>BioAssay Ontology</rdfs:label>
        <dc:license rdf:resource="https://creativecommons.org/licenses/by-sa/4.0/"/>
        <owl:versionInfo>2.8.15</owl:versionInfo>
        <rdfs:label>BAO</rdfs:label>
        https://github.com/BioAssayOntology/BAO/blob/master/bao_complete.owl
        <rdfs:comment>Contact: Stephan Schurer stephan dot schurer at med dot miami dot edu</rdfs:comment>
        <dc:date>May 30, 2025</dc:date>
    </owl:Ontology>


    <!--
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

	<!-- http://www.bioassayontology.org/bao/hasXref -->

	<owl:AnnotationProperty rdf:about="http://www.bioassayontology.org/bao/hasXref"/>
	<!-- http://www.bioassayontology.org/bao/submitted_by -->

	<owl:AnnotationProperty rdf:about="http://www.bioassayontology.org/bao/submitted_by"/>



    <!--
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

	<!-- http://www.bioassayontology.org/bao#BAO_0000006 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000006">
		<rdfs:label rdf:datatype="&xsd;string">percent cytotoxicity</rdfs:label>
		<obo:IAO_0000118>% cytotoxicity</obo:IAO_0000118>
		<obo:IAO_0000115>It is a measure of the number of dead cells in a culture well. We consider it as a subclass of &apos;percent inhibition&apos;, because cell death is induced by inhibition of vital cellular processes and percent cytotoxicity increases as the number of dead cells increases.  It can be estimated in the compound treated wells in comparison to vehicle-treated control wells and is expressed as a percent. The compound treatment is preferably performed in a short window of time to avoid masking the effect due to cell proliferation.
Compound cytotoxicity is an important parameter to measure when developing potential human therapeutics. Cytotoxicity is determined as a measure of radioisotope (3H thymidine or 51Cr) release, lactate dehydrogenase release from damaged cells, tetrazolium salt and alamar blue reduction, fluorescent dyes that selectively stain live or dead cells, and decrease in ATP content. ATP levels are detected using a luminescence based assay kit such as CellTiter-Glo (Promega). ATP values higher than controls indicate proliferation and cultures with ATP concentrations lower than controls indicate cytotoxicity.

Percent cytotoxicity = 100-percent viability</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000201"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000016 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000016">
		<rdfs:label rdf:datatype="&xsd;string">protein substrate and ligand constant</rdfs:label>
		<obo:IAO_0000115>They are used to express the binding interactions between labeled or unlabeled ligands with protein receptors and include Bmax, Kd, etc.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000033 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000033">
		<rdfs:label rdf:datatype="&xsd;string">Bmax</rdfs:label>
		<obo:IAO_0000115>It is the amount of drug required to saturate a population of receptors and a measure of the number of receptors present in the sample. It is derived from Scatchard plot of binding data. It is analogous to Vmax in enzyme kinetics.  The units of Bmax include cpm, sites/cell or fmol/mg. http://graphpad.com/curvefit/fitting_specific_binding_.htm</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000587"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000034 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000034">
		<rdfs:label rdf:datatype="&xsd;string">Kd</rdfs:label>
		<obo:IAO_0000115>Kd – is the equilibrium dissociation constant for a drug.  It describes the affinity between a ligand (L) (such as a drug) and a protein (P). Ligand-protein affinities are influenced by non-covalent intermolecular interactions between the two molecules such as hydrogen bonding, electrostatic interactions, hydrophobic and Van der Waals forces. 
Kd = ([P] [L]) / [PL]
The dissociation constant has molar units (M), which corresponds to the concentration of ligand [L] at which the binding site on a particular protein is half occupied, i.e. the concentration of ligand, at which the concentration of protein with ligand bound [PL], equals the concentration of protein with no ligand bound [P]. The smaller the dissociation constant, the more tightly bound the ligand is, or the higher the affinity between ligand and protein. http://www.graphpad.com/curvefit/law_of_mass_action.htm
        </obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000587"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000074 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000074">
		<rdfs:label rdf:datatype="&xsd;string">mode of action</rdfs:label>
		<obo:IAO_0000118>MOA</obo:IAO_0000118>
		<obo:IAO_0000115>This refers to the effect of the perturbagen on the target of an assay, whether it brings about inhibition, activation, cytotoxicity, etc. </obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0003115"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000082 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000082">
		<rdfs:label rdf:datatype="&xsd;string">percent response</rdfs:label>
		<obo:IAO_0000118>% response</obo:IAO_0000118>
		<obo:IAO_0000115>Percent increase or decrease of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000181"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000084 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000084">
		<rdfs:label rdf:datatype="&xsd;string">ligand function mode of action</rdfs:label>
		<obo:IAO_0000115>Data measuring the biological effect of a compound, e.g. % cell death, activation of reporter gene expression, inhibition of enzyme activity, etc.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000074"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000085 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000085">
		<rdfs:label rdf:datatype="&xsd;string">irreversible binding</rdfs:label>
		<obo:IAO_0000115>In this assay, the binding of the ligand to a receptor is permanent and cannot be dissociated by changing the binding conditions such as buffer, salt concentration, etc.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000476"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000086 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000086">
		<rdfs:label rdf:datatype="&xsd;string">reversible binding</rdfs:label>
		<obo:IAO_0000115>In this assay, the interaction of the ligand with a receptor can be dissociated by changing the binding conditions, e.g. buffer, salt concentration, etc.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000476"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000087 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000087">
		<rdfs:label rdf:datatype="&xsd;string">activation</rdfs:label>
		<obo:IAO_0000115>Increase of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000084"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000090 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000090">
		<rdfs:label rdf:datatype="&xsd;string">cytotoxicity</rdfs:label>
		<obo:IAO_0000115>It is the toxic or cell-death inducing property of a perturbagen. Known cytotoxic agents mediate cell death commonly by necrosis, apoptosis, or autophagy. Cytotoxicity can be detected by measuring various aspects of the death process: e.g. membrane permeability, ATP concentration, DNA fragmentation, etc.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080004"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000091 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000091">
		<rdfs:label rdf:datatype="&xsd;string">inhibition</rdfs:label>
		<obo:IAO_0000115>Reduction of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000084"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000093 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000093">
		<rdfs:label rdf:datatype="&xsd;string">stimulation</rdfs:label>
		<obo:IAO_0000115>Increase of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000084"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000094 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000094">
		<rdfs:label rdf:datatype="&xsd;string">growth inhibition</rdfs:label>
		<obo:IAO_0000115>Growth reduction of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay. 
As a measure of viable or proliferating cells, different researchers measure different parameters, namely, protein content (by sulforhodamine B staining followed by absorbance measurement), mitochondrial dehydrogenase activity (by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide, known as MTT staining followed by absorbance measurement), expression of proliferation associated antigens (by immunostaining for Ki-67), and ATP content (by using CellTiter-Glo reagent (Promega) followed by luminescence measurement.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000091"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000096 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000096">
		<rdfs:label rdf:datatype="&xsd;string">percent growth inhibition</rdfs:label>
		<obo:IAO_0000118>% growth inhibition</obo:IAO_0000118>
		<obo:IAO_0000115>% growth reduction of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000201"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000098 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000098">
		<rdfs:label rdf:datatype="&xsd;string">screening concentration</rdfs:label>
		<obo:IAO_0000115>The concentration of a perturbagen used in an assay to elicit the biological effect or perturbation. This typically assumes uniform / equal distribution of the perturbagen / compound in the assay system (typically a screening well).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000180"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000103 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000103">
		<rdfs:label rdf:datatype="&xsd;string">endpoint action correlation</rdfs:label>
		<obo:IAO_0000115>Endpoint action correlation describes weather a low or high endpoint value corresponds to low or high activity. Specifically if the endpoint value is positively or inversely correlated with the action that corresponds to the endpoint and which is specified as &apos;mode of action&apos;. For example &apos;percent control&apos; can be positively correlated with enzyme activity (remaining activity) and inversely correlated with the mode of action (function) inhibition depending on how the signal is normalized.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0003115"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000131 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000131">
		<rdfs:label rdf:datatype="&xsd;string">positively correlated</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000103"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000140 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000140">
		<rdfs:label rdf:datatype="&xsd;string">inversely correlated</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000103"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000143 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000143">
		<rdfs:label rdf:datatype="&xsd;string">percent control</rdfs:label>
		<obo:IAO_0000115>Percent control is the response relative to a reference state, typically to a high control. For example it can describe (remaining) activity of a kinase (or e.g. kinase bound to substrate).  Percent control could also quantify an inhibitory action depending on control and assay method.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000179 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000179">
		<rdfs:label rdf:datatype="&xsd;string">result</rdfs:label>
		<rdfs:label>endpoint</rdfs:label>
		<obo:IAO_0000115>The endpoint is a quantitive or qualitative interpretable standardized representation of a perturbation (a change from a defined reference state of a &quot;closed&quot; model system) that is measured by the bioassay.  An endpoint consists of a series of data points, one for each perturbing agent (screened entity) tested the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0003115"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000180 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000180">
		<rdfs:label rdf:datatype="&xsd;string">concentration endpoint</rdfs:label>
		<obo:IAO_0000115>It can refer to the screening concentration (for example in a primary assay) or it can be a concentration at which the perturbagen mediates a defined response, such as IC50 or EC50. It always has one value and a concentration unit.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000181 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000181">
		<rdfs:label rdf:datatype="&xsd;string">response endpoint</rdfs:label>
		<obo:IAO_0000115>Reporting the extent / magnitude of the perturbation (induced by the perturbagen) such as percent inhibition. Response-type endpoints would typically be obtained from a single concentration perturbagen measurement.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000186 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000186">
		<rdfs:label rdf:datatype="&xsd;string">AC50</rdfs:label>
		<obo:IAO_0000118>Potency</obo:IAO_0000118>
		<obo:IAO_0000115>The effective concentration of a perturbagen, which produces 50% of the maximal possible response, which could mean either activation (EC50) or inhibition (IC50) for that perturbagen.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000187 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000187">
		<rdfs:label rdf:datatype="&xsd;string">CC50</rdfs:label>
		<obo:IAO_0000115>The effective concentration of a cytotoxic compound, which produces 50% of the maximum possible cell death for that compound.  Although the cytotoxic compound induces cell death, we define CC50 as subclass of IC50, because critical cellular processes are inhibited and CC50 is often used as a more specific description of IC50 for cell toxicity assays.
Compound cytotoxicity is an important parameter to measure when developing potential human therapeutics. Cytotoxicity can be determined for example as a measure of radioisotope (3H thymidine or 51Cr) release, lactate dehydrogenase release from damaged cells, tetrazolium salt and alamar blue reduction, fluorescent dyes that selectively stain live or dead cells,  or decrease in ATP content. ATP levels are detected using a luminescence based assay kit such as CellTiter-Glo (Promega). ATP values higher than controls (untreated cells) indicate proliferation and cultures with ATP concentrations lower than controls indicate cytotoxicity.
</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000188 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000188">
		<rdfs:label rdf:datatype="&xsd;string">EC50</rdfs:label>
		<obo:IAO_0000115>The effective concentration of an agonist, which produces 50% of the maximum possible response for that agonist.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000189 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000189">
		<rdfs:label rdf:datatype="&xsd;string">GI50</rdfs:label>
		<obo:IAO_0000118>growth inhibition by 50%</obo:IAO_0000118>
		<obo:IAO_0000115>The effective concentration of a growth inhibitor, which produces 50% of the maximum possible response for that inhibitor. GI50 is calculated from [(Ti-Tz)/(C-Tz)] x 100 = 50, where Tz is absorbance at time zero, Ti is absorbance in the presence of test drug, and C is absorbance in the control (untreated cells). 
As a measure of viable or proliferating cells, different researchers measure different parameters, namely, protein content (by sulforhodamine B staining followed by absorbance measurement), mitochondrial dehydrogenase activity (by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide, known as MTT staining followed by absorbance measurement), expression of proliferation associated antigens (by immunostaining for Ki-67), and ATP content (by using CellTiter-Glo reagent (Promega) followed by luminescence measurement).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000190 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000190">
		<rdfs:label rdf:datatype="&xsd;string">IC50</rdfs:label>
		<obo:IAO_0000115>The effective concentration of an inhibitor, which produces 50% of the maximum possible response for that inhibitor.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000191 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000191">
		<rdfs:label rdf:datatype="&xsd;string">IC80</rdfs:label>
		<obo:IAO_0000115>The effective concentration of an inhibitor, which produces 80% of the maximum possible response for that inhibitor.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000192 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000192">
		<rdfs:label rdf:datatype="&xsd;string">Ki</rdfs:label>
		<obo:IAO_0000115>Ki is the equilibrium inhibitor dissociation constant, the concentration of the competing inhibitor that results in binding to half the enzymes sites at equilibrium in the absence of substrate or other competitors.
The Cheng and Prusoff equation: Ki - (IC50) / ( 1+ ([L]/Kd)) relates IC50 to Ki under conditions of competitive binding; Kd equilibrium dissociation constant of the (labeled) ligand, [L] ligand concentration.
The Cheng and Prusoff equation: Ki - (IC50) / ( 1+ ([S]/Km)) relates IC50 to Ki under conditions of competitive inhibition; Ki equilibrium enzyme inhibitor dissociation constant; Km Michaelis-Menton constant, [S] substrate concentration.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000587"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000193 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000193">
		<rdfs:label rdf:datatype="&xsd;string">fold change</rdfs:label>
		<obo:IAO_0000115>It is the ratio of biological activity in the presence of an exogenous substance to that in its absence. The fold change is useful when comparing test compounds evaluated across multiple functional assays because varying levels of efficacy can be observed amongst the different or same reference agonists.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000181"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000194 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000194">
		<rdfs:label rdf:datatype="&xsd;string">TGI</rdfs:label>
		<obo:IAO_0000118>total growth inhibition</obo:IAO_0000118>
		<obo:IAO_0000115>TGI is total growth inhibition, which is the effective concentration of a growth inhibitor, which produces 0% relative growth for that inhibitor. Thus TGI signifies a cytostatic effect.
tgi is calculated from [(Ti-Tz)/(C-Tz)] x 100 =0, where Ti = Tz and Tz is absorbance at time zero, Ti is absorbance in the presence of test drug, and C is absorbance in the control (untreated cells). 
As a measure of viable cells, different researchers measure different parameters, namely, protein content (by sulforhodamine B staining followed by absorbance measurement), mitochondrial dehydrogenase activity (by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrasodium bromide, known as MTT staining followed by absorbance measurement), and ATP content (by using CellTiter-Glo reagent (Promega) followed by luminescence measurement).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000197 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000197">
		<rdfs:label rdf:datatype="&xsd;string">IC50 absolute</rdfs:label>
		<obo:IAO_0000115>Absolute IC50 (calculated from the curve-fit function) is the concentration corresponding to exactly 50 percent inhibition. It is obtained from the curve fit function (back-calculated IC50) and can also be extrapolated. Commonly the relative IC50 is reported; however in cell proliferation assays absolute IC50 is often used. The absolute IC50 can be more reproducible.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000190"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000198 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000198">
		<rdfs:label rdf:datatype="&xsd;string">IC50 relative</rdfs:label>
		<obo:IAO_0000115>The concentration of a test substance that produces an inhibitory effect corresponding to 50% of the activity of that particular substance (i.e. 50% of the difference between top and bottom of fitted curve). It can also be described as the concentration corresponding to the inflection point of the curve.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000190"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000199 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000199">
		<rdfs:label rdf:datatype="&xsd;string">pIC50</rdfs:label>
		<obo:IAO_0000118>-log IC50</obo:IAO_0000118>
		<obo:IAO_0000115>pIC50 is -log IC50, where IC50 is the effective concentration of an inhibitor, which produces 50% of the maximum possible response for that inhibitor.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000190"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000200 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000200">
		<rdfs:label rdf:datatype="&xsd;string">percent activation</rdfs:label>
		<obo:IAO_0000118>% activation</obo:IAO_0000118>
		<obo:IAO_0000115>Percent increase of a measureable response relative to some baseline. Unit of Measure is always % when normalized to the dynamic range of the assay.
Percent activity measures the increased activity vs. an unperturbed state, i.e. percent activation := percent activity - 100; e.g. an agonist that results in twice the activity would have percent activity = 200 and percent activation = 100.
</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000201 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000201">
		<rdfs:label rdf:datatype="&xsd;string">percent inhibition</rdfs:label>
		<obo:IAO_0000115>Percent decrease of a measureable response as a consequence of compound treatment.  Unit of Measure is always % when normalized to the dynamic range of the assay. Percent inhibition is expressed relative to a positive control (which results in total inhibition).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000202 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000202">
		<rdfs:label rdf:datatype="&xsd;string">percent cell viability</rdfs:label>
		<obo:IAO_0000118>% viability</obo:IAO_0000118>
		<obo:IAO_0000115>It is a measure of living cells in a culture well. Unit of Measure is always % when normalized to the dynamic range of the assay. It can be estimated in the compound treated wells in comparison to vehicle-treated control wells and is expressed as a percent.
Viability is determined by measuring tetrazolium salt and alamar blue reduction, staining with selective fluorescent dyes, or ATP content. ATP levels are detected using a luminescence based assay kit such as CellTiter-Glo (Promega). ATP values higher than controls indicate proliferation and cultures with ATP concentrations lower than controls indicates cytotoxicity.
Percent viability = 100-percent cytotoxicity</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0001103"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000260 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000260">
		<rdfs:label rdf:datatype="&xsd;string">signal increase corresponding to activation</rdfs:label>
		<obo:IAO_0000115>Increase in perturbation (reported by the endpoint mode of action, activation) is correlated to increase in signal.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080026"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000261 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000261">
		<rdfs:label rdf:datatype="&xsd;string">signal decrease corresponding to inhibition</rdfs:label>
		<obo:IAO_0000115>Increase in perturbation (reported by the endpoint mode of action, inhibition) is correlated to decrease in signal.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080025"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000346 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000346">
		<rdfs:label rdf:datatype="&xsd;string">50 percent activation</rdfs:label>
		<obo:IAO_0000118>50% activation</obo:IAO_0000118>
		<obo:IAO_0000115>50% increase of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000200"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000347 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000347">
		<rdfs:label rdf:datatype="&xsd;string">50 percent inhibition</rdfs:label>
		<obo:IAO_0000118>50% inhibition</obo:IAO_0000118>
		<obo:IAO_0000115>50% reduction of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000201"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000348 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000348">
		<rdfs:label rdf:datatype="&xsd;string">80 percent inhibition</rdfs:label>
		<obo:IAO_0000118>80% inhibition</obo:IAO_0000118>
		<obo:IAO_0000115>80% reduction of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000201"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000349 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000349">
		<rdfs:label rdf:datatype="&xsd;string">50 percent cell viability</rdfs:label>
		<obo:IAO_0000118>50% viability</obo:IAO_0000118>
		<obo:IAO_0000115>Assay has 50% living cells. Unit of Measure is always % when normalized to the dynamic range of the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000202"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000375 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000375">
		<rdfs:label rdf:datatype="&xsd;string">fold activation</rdfs:label>
		<obo:IAO_0000115>The ratio of biological activity in the presence of an exogenous substance to that in its absence. This result type is used exclusively with single point (screening concentration) assays.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000193"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000376 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000376">
		<rdfs:label rdf:datatype="&xsd;string">fold inhibition</rdfs:label>
		<obo:IAO_0000115>The ratio of biological activity in the absence of an exogenous substance to that in its presence. This result type is used exclusively with single point (screening concentration) assays.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000193"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000430 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000430">
		<rdfs:label rdf:datatype="&xsd;string">B-score</rdfs:label>
		<obo:IAO_0000115>The B score is an analog of the Z score, but is more resistant to the presence of outliers and to differences in the measurement error distributions of the compounds. It is calculated by first computing a two-way median to account for row and column effects of the plate,  which is then divided by their median absolute deviation to standardize for plate-to-plate variability.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002126"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000432 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000432">
		<rdfs:label rdf:datatype="&xsd;string">Z-score</rdfs:label>
		<obo:IAO_0000115>Random and systematic error can induce either underestimation (false negatives) or overestimation (false positives) of measured signals. Z score indicates how many standard deviations an observation is above or below the mean. For calculating this, the average of the plate values is subtracted from individual raw values and the difference divided by the standard deviation estimated from all measurements of the plate.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002126"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000434 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000434">
		<rdfs:label rdf:datatype="&xsd;string">curve fit specification</rdfs:label>
		<obo:IAO_0000115>Has curve fit parameters, curve fit method, properties like Hill coefficient, concentration range, and measurement repetition. It involves capturing the trend in the data by assigning a single function across the entire range. The goal of curve fitting is to find the parameter values that most closely match the data.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0003115"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000435 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000435">
		<rdfs:label rdf:datatype="&xsd;string">Hill equation</rdfs:label>
		<obo:IAO_0000115>The Hill equation is commonly used to estimate the number of ligand molecules that are required to bind to a receptor to produce a functional effect. The Hill coefficient can be considered as an interaction coefficient, reflecting the extent of cooperativity among multiple ligand binding sites.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000625"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000441 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000441">
		<rdfs:label rdf:datatype="&xsd;string">competitive binding</rdfs:label>
		<obo:IAO_0000115>An assay based on the competition between a labeled and an unlabeled ligand in the reaction with a receptor binding agent (e.g. antibody, receptor, transport protein).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000476"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000442 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000442">
		<rdfs:label rdf:datatype="&xsd;string">non-competitive binding</rdfs:label>
		<obo:IAO_0000115>Non-competitive ligands interact with receptors at sites distinct from the competitive ligand binding pocket, conferring multiple modes of action.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000476"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000443 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000443">
		<rdfs:label rdf:datatype="&xsd;string">input data</rdfs:label>
		<obo:IAO_0000115>It identifies whether the data has been normalized (by Z and Z&apos; factors, signal to background, signal to noise, and coefficient of variance), or if it was an immediate readout obtained from a HTS assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000434"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000444 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000444">
		<rdfs:label rdf:datatype="&xsd;string">normalized data</rdfs:label>
		<obo:IAO_0000115>Data can be normalized by Z and Z&apos; factors, signal to background, signal to noise, and coefficient of variance. Plate based normalization is usually based on controls. In the absence of controls, the Z-score can be used to normalize the data by plate.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000443"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000445 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000445">
		<rdfs:label rdf:datatype="&xsd;string">raw data</rdfs:label>
		<obo:IAO_0000115>The readout obtained from a HTS assay which includes measurements from the positive and negative control wells in each plate. This is the data that needs to be processed.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000443"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000476 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000476">
		<rdfs:label rdf:datatype="&xsd;string">ligand binding mode of action</rdfs:label>
		<obo:IAO_0000115>Concepts describing the type of perturbagen interaction with the receptor.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000074"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000477 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000477">
		<rdfs:label rdf:datatype="&xsd;string">km</rdfs:label>
		<obo:IAO_0000115>The concentration of substrate at ½ Vmax, according to the Henri-Michaelis-Menten kinetic model.
        </obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000487"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000479 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000479">
		<rdfs:label rdf:datatype="&xsd;string">koff</rdfs:label>
		<obo:IAO_0000115>The off-rate associated with the release of inhibitor from an enzyme-inhibitor complex.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000487"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000480 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000480">
		<rdfs:label rdf:datatype="&xsd;string">kon</rdfs:label>
		<obo:IAO_0000115>The on-rate associated with the formation of an enzyme-inhibitor complex.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000487"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000481 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000481">
		<rdfs:label rdf:datatype="&xsd;string">kcat</rdfs:label>
		<obo:IAO_0000115>Turnover number representing the maximum number of substrate molecules converted to products per active site per unit time.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000487"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000482 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000482">
		<rdfs:label rdf:datatype="&xsd;string">competitive inhibition</rdfs:label>
		<obo:IAO_0000115>A competitive inhibitor binds only to free enzyme. Often this binding event occurs on the active site of the target, precisely where substrate also binds. It will raise the apparent KM value for its substrate with no change in the apparent Vmax value. As a result, competitive inhibition can be overcome, observed by an increase in the apparent KI value, at higher concentrations of substrate.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000091"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000483 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000483">
		<rdfs:label rdf:datatype="&xsd;string">uncompetitive inhibition</rdfs:label>
		<obo:IAO_0000115>An uncompetitive inhibitor binds exclusively to the enzyme-substrate complex yielding an inactive enzyme-substrate-inhibitor complex. When encountered, the apparent Vmax value and the apparent KM value should both decrease.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000091"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000485 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000485">
		<rdfs:label rdf:datatype="&xsd;string">non-competitive inhibition</rdfs:label>
		<obo:IAO_0000115>A noncompetitive inhibitor binds equally well to both free enzyme and the enzyme-substrate complex. These binding events occur exclusively at a site distinct from the precise active site occupied by substrate. It will lower the apparent Vmax value, yet there is no effect on the apparent KM value for its substrate. Essentially, the KI of the inhibitor does not change as a function of the substrate concentration.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000091"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000487 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000487">
		<rdfs:label rdf:datatype="&xsd;string">enzyme kinetic constant</rdfs:label>
		<obo:IAO_0000115>Describe kinetics of enzyme-catalyzed reactions. It includes the enzyme kinetic constants namely, Km and Vmax, which help to model the time course of disappearance of substrate and the production of product.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000016"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000488 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000488">
		<rdfs:label rdf:datatype="&xsd;string">partial inhibition</rdfs:label>
		<obo:IAO_0000115>Partial inhibition results from the formation of an enzyme-substrate-inhibitor complex that can generate product with less efficiency than the enzyme-substrate complex.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000091"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000489 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000489">
		<rdfs:label rdf:datatype="&xsd;string">allosteric modulation</rdfs:label>
		<obo:IAO_0000115>An allosteric effector operates to enhance active site substrate affinity and/or catalysis.
An allosteric inhibitor decreases activity by binding to an allosteric site, other than or in addition to the active site on the target. This interaction is characterized by a conformational change in the target enzyme that is required for inhibition.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002909"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000490 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000490">
		<rdfs:label rdf:datatype="&xsd;string">tight binding inhibition</rdfs:label>
		<obo:IAO_0000115>In this type of inhibition, the population of free, soluble inhibitor is significantly depleted by the formation of the enzyme-inhibitor or enzyme-substrate-inhibitor complex. While tight-binding inhibitors can bind to the target enzyme in a competitive, noncompetitive, or uncompetitive manner with respect to substrate binding, they can display noncompetitive phenotypes.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000091"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000491 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000491">
		<rdfs:label rdf:datatype="&xsd;string">time dependent inhibition</rdfs:label>
		<obo:IAO_0000115>Time-dependent inhibitors bind slowly to the enzyme on the time scale of enzymatic turnover, and thus display a change in initial velocity with time. This has the effect of slowing the observed onset of inhibition.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000091"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000519 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000519">
		<rdfs:label rdf:datatype="&xsd;string">signal direction</rdfs:label>
		<obo:IAO_0000115>It is the trend of measured readout signal, whether it increases or decreases in perturbagen treated wells, as compared to the untreated or carrier-treated wells and the endpoint mode of action of an assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0003115"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000579 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000579">
		<rdfs:label rdf:datatype="&xsd;string">saturation binding</rdfs:label>
		<obo:IAO_0000115>These experiments measure specific radioligand binding at equilibrium at various concentrations of the radioligand.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000476"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000581 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000581">
		<rdfs:label rdf:datatype="&xsd;string">Tm</rdfs:label>
		<obo:IAO_0000118>melting temperature</obo:IAO_0000118>
		<obo:IAO_0000115>Tm is defined as the midpoint temperatuere of the protein unfolding transition. It is determined by generating a thermal denaturation curve for the target molecule and taking the midpoint temperature between folding and unfolding state of the protein.
In nucleic acid thermodynamics, it is the temperature at which 50% of the DNA strands and its perfect complement are in duplex.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000585"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000583 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000583">
		<rdfs:label rdf:datatype="&xsd;string">raw activity</rdfs:label>
		<obo:IAO_0000115>Raw or qualitative data are reported as endpoints in an assay, e.g., luminescence counts, fluorescence intensity, etc.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000181"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000585 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000585">
		<rdfs:label rdf:datatype="&xsd;string">temperature endpoint</rdfs:label>
		<obo:IAO_0000115>The types of endpoints that report changes in temperature as a measure of a biological reaction, e.g. tm.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000586 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000586">
		<rdfs:label rdf:datatype="&xsd;string">vmax</rdfs:label>
		<obo:IAO_0000115>Vmax is defined as the maximum initial velocity of an enzyme catalyzed reaction under the given conditions, and it is measured in units of quantity of substrate transformed per unit time for a given concentration of enzyme.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000487"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000587 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000587">
		<rdfs:label rdf:datatype="&xsd;string">binding constant</rdfs:label>
		<obo:IAO_0000115>This endpoint type describes the bonding affinity between two molecules at equilibrium, e.g., drug-receptor interaction.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000016"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000588 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000588">
		<rdfs:label rdf:datatype="&xsd;string">50 percent cytotoxicity</rdfs:label>
		<obo:IAO_0000115>The perturbagen mediated 50% of cells to die in an assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000006"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000599 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000599">
		<rdfs:label rdf:datatype="&xsd;string">EC30</rdfs:label>
		<obo:IAO_0000115>The effective concentration of an agonist, which produces 30% of the maximum possible response for that agonist.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000610 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000610">
		<rdfs:label rdf:datatype="&xsd;string">PubChem endpoint name</rdfs:label>
		<obo:IAO_0000115>It is the term that describes an endpoint or result of a bioassay, which is deposited at PubChem.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0003115"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000625 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000625">
		<rdfs:label rdf:datatype="&xsd;string">curve fit model</rdfs:label>
		<obo:IAO_0000115>A mathematical model / equation to which the data is fitted (using the curve fit method / algorithm).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000434"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000626 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000626">
		<rdfs:label rdf:datatype="&xsd;string">3 parameter Hill equation</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000435"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000629 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000629">
		<rdfs:label rdf:datatype="&xsd;string">4 parameter Hill equation</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000435"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000656 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000656">
		<rdfs:label rdf:datatype="&xsd;string">efficacy</rdfs:label>
		<obo:IAO_0000118>Efficacy</obo:IAO_0000118>
		<obo:IAO_0000115>The maximum response that can be achieved with the perturbagen as percentage of the positive control.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000804 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000804">
		<rdfs:label rdf:datatype="&xsd;string">maximal inhibition</rdfs:label>
		<obo:IAO_0000115>Maximum inhibition of an antagonist or inhibitor (relative an efficacious positive control)</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000656"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0000805 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0000805">
		<rdfs:label rdf:datatype="&xsd;string">maximal activation</rdfs:label>
		<obo:IAO_0000115>The maximum percent activation of an agonist</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000656"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001103 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001103">
		<rdfs:label rdf:datatype="&xsd;string">percent activity</rdfs:label>
		<obo:IAO_0000115>Percent activity is the response relative to an unperturbed state; in case of inhibition the interpretation is that of remaining activity, i.e. percent inhibition := 100 - percent activity.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001106 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001106">
		<rdfs:label rdf:datatype="&xsd;string">50 percent growth inhibition</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000096"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001108 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001108">
		<rdfs:label rdf:datatype="&xsd;string">100 percent growth inhibition</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000096"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001235 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001235">
		<rdfs:label rdf:datatype="&xsd;string">EC20</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001236 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001236">
		<rdfs:label rdf:datatype="&xsd;string">EC150</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001237 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001237">
		<rdfs:label rdf:datatype="&xsd;string">EC90</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001238 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001238">
		<rdfs:label rdf:datatype="&xsd;string">IC95</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001239 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001239">
		<rdfs:label rdf:datatype="&xsd;string">MIC80</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001240 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001240">
		<rdfs:label rdf:datatype="&xsd;string">MIC90</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001241 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001241">
		<rdfs:label rdf:datatype="&xsd;string">ED</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002116"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001242 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001242">
		<rdfs:label rdf:datatype="&xsd;string">ED25</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002116"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001243 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001243">
		<rdfs:label rdf:datatype="&xsd;string">ED30</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002116"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001244 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001244">
		<rdfs:label rdf:datatype="&xsd;string">ED90</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002116"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001245 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001245">
		<rdfs:label rdf:datatype="&xsd;string">LD10</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002116"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001246 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001246">
		<rdfs:label rdf:datatype="&xsd;string">ID50</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002116"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001247 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001247">
		<rdfs:label rdf:datatype="&xsd;string">MinED</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002116"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001248 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001248">
		<rdfs:label rdf:datatype="&xsd;string">MTD</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002116"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001249 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001249">
		<rdfs:label rdf:datatype="&xsd;string">TD50</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002116"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001250 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001250">
		<rdfs:label rdf:datatype="&xsd;string">maximal effect</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000656"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001251 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001251">
		<rdfs:label rdf:datatype="&xsd;string">Increase</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001252 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001252">
		<rdfs:label rdf:datatype="&xsd;string">percent change</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001253 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001253">
		<rdfs:label rdf:datatype="&xsd;string">percent growth</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001254 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001254">
		<rdfs:label rdf:datatype="&xsd;string">percent protection</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001255 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001255">
		<rdfs:label rdf:datatype="&xsd;string">percent remaining</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001256 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001256">
		<rdfs:label rdf:datatype="&xsd;string">uptake</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001257 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001257">
		<rdfs:label rdf:datatype="&xsd;string">efflux ratio</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002128"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001258 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001258">
		<rdfs:label rdf:datatype="&xsd;string">Kinactivation</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000587"/>
		<obo:IAO_0000115>maximum rate of inactivation</obo:IAO_0000115>
		<obo:IAO_0000118>kinact</obo:IAO_0000118>
		<bao:submitted_by>https://github.com/Scientist328455</bao:submitted_by>
		<bao:hasXref>https://doi.org/10.1177/1087057116671509</bao:hasXref>
		<bao:hasXref>https://doi.org/10.1177/1087057116671509</bao:hasXref>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001259 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001259">
		<rdfs:label rdf:datatype="&xsd;string">residence time</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002114"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001260 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001260">
		<rdfs:label rdf:datatype="&xsd;string">T</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002114"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001262 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001262">
		<rdfs:label rdf:datatype="&xsd;string">ED80</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002116"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001263 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001263">
		<rdfs:label rdf:datatype="&xsd;string">EC10</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001264 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001264">
		<rdfs:label rdf:datatype="&xsd;string">EC25</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001265 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001265">
		<rdfs:label rdf:datatype="&xsd;string">IC75</rdfs:label>
		<rdfs:comment>IRI prefix change from BAO_02000 to BAO_00012 in January 2017</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001490 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001490">
		<rdfs:label rdf:datatype="&xsd;string">negative allosteric modulation</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000489"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0001491 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0001491">
		<rdfs:label rdf:datatype="&xsd;string">positive allosteric modulation</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000489"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002006 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002006">
		<rdfs:label rdf:datatype="&xsd;string">percent apoptotic cells</rdfs:label>
		<obo:IAO_0000115>The percentage of cells in an assay that show the hallmarks of &apos;programmed cell death&apos; or apoptosis, namely, membrane asymmetry, caspase activation, nuclear fragmentation, etc.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000006"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002040 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002040">
		<rdfs:label rdf:datatype="&xsd;string">percent mitotic cells</rdfs:label>
		<obo:IAO_0000115>This represents the percentage of cells in a cell population that are in the M phase of the cell cycle. The cells in this phase can be detected using various markers, one of which is the characteristic phosphorylation of certain proteins that stain positive with MPM2 antibody.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0001103"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002042 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002042">
		<rdfs:label rdf:datatype="&xsd;string">percent interphase cells</rdfs:label>
		<rdfs:comment>&apos;has marker&apos; some (not (&apos;DEVD-NucView 488&apos; or &apos;LysoTracker Red&apos; or &apos;Hoechst 33342&apos;)) </rdfs:comment>
		<obo:IAO_0000115>This represents the percentage of cells in a cell population that are preparing for cell division and that exist in either G1, S or G2 phases of the cell cycle. This is calculated by subtracting from the total cell number, the number of cells in the M phase, apoptotic and dead cells in an assay plate.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0001103"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002044 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002044">
		<rdfs:label rdf:datatype="&xsd;string">percent DNA replicated cells</rdfs:label>
		<obo:IAO_0000115>This represents the percentage of cells in a cell population that have undergone the S phase (completed DNA replication) in preparation for mitosis, as indicated by staining positive for EdU.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0001103"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002046 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002046">
		<rdfs:label rdf:datatype="&xsd;string">percent dead cells</rdfs:label>
		<rdfs:comment>&apos;has marker&apos; some (&apos;Hoechst 33342&apos; and not (&apos;DEVD-NucView 488&apos; or &apos;LysoTracker Red&apos;) ) </rdfs:comment>
		<obo:IAO_0000115>The percentage of cells in an assay that are no longer alive (viable), and show the characteristic features, such as staining with propidium iodide, blurry staining with DAPI, etc.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000006"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002081 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002081">
		<rdfs:label rdf:datatype="&xsd;string">percent G2 arrested cells</rdfs:label>
		<obo:IAO_0000115>This represents the percentage of cells in a cell population that have undergone the DNA synthesis in the S phase as indicated by staining positive for EdU, but have not undergone the M phase as they stained negative for MDM2. In other words, these cells were arrested in the G2/M cell cycle check-points after treatment with the respective perturbagen in the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0001103"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002082 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002082">
		<rdfs:label rdf:datatype="&xsd;string">percent non-arrested cells</rdfs:label>
		<obo:IAO_0000115>This represents the percentage of cells in a cell population that have completed the mitotic cell cycle, and that have stained positive for both S phase (EdU) and M phase (MDM2) markers. In other words, these cells were not arrested in any of the cell cycle check-points after treatment with the respective perturbagen in the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0001103"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002114 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002114">
		<rdfs:label rdf:datatype="&xsd;string">time endpoint</rdfs:label>
		<obo:IAO_0000115>An endpoint defined by a length in time at which a desired effect or observation occurs.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002115 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002115">
		<rdfs:label rdf:datatype="&xsd;string">T1/2</rdfs:label>
		<obo:IAO_0000115>Half-life of drug is the time taken for the concentration of the drug to decrease by half.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002114"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002116 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002116">
		<rdfs:label rdf:datatype="&xsd;string">dosage endpoint</rdfs:label>
		<obo:IAO_0000115>An endpoint defined an effect seen in animals at a particular dosage, typically defined as a ratio of treatment to animal mass (e.g., mg/kg).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000180"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002117 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002117">
		<rdfs:label rdf:datatype="&xsd;string">LD50</rdfs:label>
		<obo:IAO_0000118>lethal dose 50%</obo:IAO_0000118>
		<obo:IAO_0000115>The median lethal dose is the dose required to kill (produce lethality) in 50% of tested population.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002116"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002118 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002118">
		<rdfs:label rdf:datatype="&xsd;string">graphical calculation endpoint</rdfs:label>
		<obo:IAO_0000115>An endpoint derived from calculus-based analysis of graphical measures.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002119 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002119">
		<rdfs:label rdf:datatype="&xsd;string">Cmax</rdfs:label>
		<obo:IAO_0000115>The maximal concentration of a drug achieved following administration (maximum point of a concentration-time curve).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002118"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002120 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002120">
		<rdfs:label rdf:datatype="&xsd;string">AUC</rdfs:label>
		<obo:IAO_0000118>area under curve</obo:IAO_0000118>
		<obo:IAO_0000115>It is the area under the drug concentration-time curve (AUC) following a single dose or at steady state, and is expressed as weight*time/volume.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002118"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002121 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002121">
		<rdfs:label rdf:datatype="&xsd;string">slope</rdfs:label>
		<obo:IAO_0000115>Slope is described as the ratio of the change in y-axis divided by the change in x-axis between two points on a line or a curve.

m= y2-y1 / x2-x1</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002118"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002122 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002122">
		<rdfs:label rdf:datatype="&xsd;string">amplification curve calculated endpoint</rdfs:label>
		<obo:IAO_0000115>Endpoint values derived from an exponential growth curve, such as in a PCR reaction.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002118"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002123 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002123">
		<rdfs:label rdf:datatype="&xsd;string">Cp</rdfs:label>
		<obo:IAO_0000118>crossing point</obo:IAO_0000118>
		<obo:IAO_0000115>Crossing point- In an exponential amplification curve (i.e., qPCR amplification) the value in number of amplification cycles at which the signal enters log phase, as determined by the maximal second derivative of the curve.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002122"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002124 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002124">
		<rdfs:label rdf:datatype="&xsd;string">Cq</rdfs:label>
		<obo:IAO_0000118>quantificatoin cycle</obo:IAO_0000118>
		<obo:IAO_0000115>Quantificatoin cycle; general term, whether defined by Cp or Ct, for the value of interest determined from an exponential amplification curve (such as number of cycles in a PCR reaction).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002122"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002125 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002125">
		<rdfs:label rdf:datatype="&xsd;string">Ct</rdfs:label>
		<obo:IAO_0000118>threshold cycle</obo:IAO_0000118>
		<obo:IAO_0000115>Crossing threshold; in an exponential amplification curve (i.e., qPCR amplification) the value in number of amplification cycles at which the signal crosses a defined threshold.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002122"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002126 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002126">
		<rdfs:label rdf:datatype="&xsd;string">statistical endpoint</rdfs:label>
		<obo:IAO_0000115>Endpoint values determined by a statistical measurement of the signal relative to the populations of signals observed.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000181"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002127 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002127">
		<rdfs:label rdf:datatype="&xsd;string">MAD score</rdfs:label>
		<obo:IAO_0000115>The number of median absolute deviations outside the median of control or compound wells.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002126"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002128 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002128">
		<rdfs:label rdf:datatype="&xsd;string">physical property endpoint</rdfs:label>
		<obo:IAO_0000115>A measurement of an intrinsic property of a molecular entity.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002129 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002129">
		<rdfs:label rdf:datatype="&xsd;string">logD</rdfs:label>
		<obo:IAO_0000115>Logarithm (log10) of the Distribution Coefficient, D, which is defined as the ratio of concentrations  of a small molecule / drug distributed between octanol and water.  LogD refers to the distribution of all forms of a compound between the two immiscible phases at equilibrium. It depends on pH of the aqueous phase, which is buffered to a specific value. A larger logD means the compound / drug is more hydrophobic (greasy) and a lower logD corresponds to better solubility in water.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002128"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002130 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002130">
		<rdfs:label rdf:datatype="&xsd;string">logP</rdfs:label>
		<obo:IAO_0000115>Logarithm (log10) of the Partition Coefficient, P, which is defined as ratio of concentrations of a small molecule / drug distributed in octanol and water.  LogP refers to the distribution of un-ionized (neutral species of) compound between the two immiscible phases at equilibrium; the pH is adjusted such that the major microspecies is the un-ionized form. A larger logP means the compound / drug is more hydrophobic (greasy) and a lower logP corresponds to better solubility in water.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002128"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002131 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002131">
		<rdfs:label rdf:datatype="&xsd;string">pKa</rdfs:label>
		<obo:IAO_0000115>pKa is the negative log10 of the acid dissociation constant (Ka) of a molecule. Ka is the equilibrium constant for dissociation of the protonated base (acid) into the free base and a proton (hydromium ion).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002128"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002132 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002132">
		<rdfs:label rdf:datatype="&xsd;string">percent purity</rdfs:label>
		<obo:IAO_0000115>Percent purity is the ratio of mass of pure compound to the actual mass of the available/vendor supplied compound, multiplied by 100. The majority of compounds and elemental substances are only available with a larger or smaller amount of impurities, which contribute to the mass of the impure compound.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002128"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002133 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002133">
		<rdfs:label rdf:datatype="&xsd;string">permeability A-B</rdfs:label>
		<obo:IAO_0000115>This is measured to assess the transport of a drug across the cell monolayer in the apical to basolateral (A-B) direction. Typically, CaCo2 cells are used in the permeability measurements during the ADME phase, which model the intestinal epithelium..</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002808"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002134 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002134">
		<rdfs:label rdf:datatype="&xsd;string">permeability B-A</rdfs:label>
		<obo:IAO_0000115>This is measured to assess the transport of a drug across the cell monolayer in the basolateral to apical (B-A) direction. Typically, CaCo2 cells are used in the permeability measurements during the ADME phase, which model the intestinal epithelium.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002808"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002135 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002135">
		<rdfs:label rdf:datatype="&xsd;string">solubility</rdfs:label>
		<obo:IAO_0000115>The ability of a chemical substance to dissolve in a solid, liquid, or gaseous solvent to form a homogeneous solution. The solubility of a given substance is dependent on the solvent used, as well as on temperature and pressure.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002128"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002136 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002136">
		<rdfs:label rdf:datatype="&xsd;string">profile endpoint</rdfs:label>
		<obo:IAO_0000115>An endpoint defined by a set of measurements from a multiparametric assay.  The set of measurements may be aggregated to an overall profile score, weighting each measurment in the profile relative to a desired outcome.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002137 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002137">
		<rdfs:label rdf:datatype="&xsd;string">computational profile endpoint</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002136"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002138 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002138">
		<rdfs:label rdf:datatype="&xsd;string">gene-expression profile endpoint</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002136"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002139 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002139">
		<rdfs:label rdf:datatype="&xsd;string">panel-assay profile endpoint</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002136"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002144 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002144">
		<rdfs:label rdf:datatype="&xsd;string">IC90</rdfs:label>
		<obo:IAO_0000115>The effective concentration of an inhibitor, which produces 90% of the maximum possible response for that inhibitor.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002145 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002145">
		<rdfs:label rdf:datatype="&xsd;string">LC50</rdfs:label>
		<obo:IAO_0000115>It is 50% lethal concentration (the concentration that kills 50% of treated cells).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002146 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002146">
		<rdfs:label rdf:datatype="&xsd;string">MIC</rdfs:label>
		<obo:IAO_0000118>minimum inhibitory concentration</obo:IAO_0000118>
		<obo:IAO_0000115>The lowest concentration of an inhibitor (antimicrobial agent) required to inhibit the growth of a microorganism.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002147 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002147">
		<rdfs:label rdf:datatype="&xsd;string">percent bound</rdfs:label>
		<obo:IAO_0000115>It is a measure of the amount of radioligand that binds to its receptor in a competitive binding assay. It is the ratio of the bound to the total bound, where bound refers to the reading obtained from a binding reaction involving radioligand, receptor and a cold competitor ligand, while total bound is the reading obtained in the absence of any added competitor.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002148 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002148">
		<rdfs:label rdf:datatype="&xsd;string">percent recovery</rdfs:label>
		<obo:IAO_0000115>In a purification assay, percent recovery is the ratio of mass of the entity obtained after the affinity purification to the mass of the unpurified entity originally added in the assay, multiplied by 100.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000082"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002152 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002152">
		<rdfs:label rdf:datatype="&xsd;string">signal decrease corresponding to activation</rdfs:label>
		<obo:IAO_0000115>Increase in perturbation (reported by the endpoint mode of action, activation) is correlated to decrease in signal.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080025"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002153 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002153">
		<rdfs:label rdf:datatype="&xsd;string">signal increase corresponding to inhibition</rdfs:label>
		<obo:IAO_0000115>Increase in perturbation (reported by the endpoint mode of action, inhibition) is correlated to increase in signal.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080026"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002162 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002162">
		<rdfs:label rdf:datatype="&xsd;string">concentration response endpoint</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000180"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002583 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002583">
		<rdfs:label rdf:datatype="&xsd;string">pEC50</rdfs:label>
		<obo:IAO_0000118>-log EC50</obo:IAO_0000118>
		<obo:IAO_0000115>pEC50 is -logEC50, where EC50 is the effective concentration of an agonist, which produces 50% of the maximum possible response for that agonist.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000188"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002667 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002667">
		<rdfs:label rdf:datatype="&xsd;string">90 percent inhibition</rdfs:label>
		<obo:IAO_0000118>90% inhibition</obo:IAO_0000118>
		<obo:IAO_0000115>90% reduction of a predefined stimulus. Unit of Measure is always % when normalized to the dynamic range of the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000201"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002752 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002752">
		<rdfs:label rdf:datatype="&xsd;string">measured concentration</rdfs:label>
		<obo:IAO_0000115>Measured / detected concentration of the perturbagen / compound in the assay or a subsystem (locally) in the assay. For example measured absolute concentration in the brain. This is in contrast to screening concentration, which is the (final assumed) concentration of a compound added to the assay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000180"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002758 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002758">
		<rdfs:label rdf:datatype="&xsd;string">volume endpoint</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002759 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002759">
		<rdfs:label rdf:datatype="&xsd;string">CL</rdfs:label>
		<obo:IAO_0000118>Drug clearance</obo:IAO_0000118>
		<obo:IAO_0000115>Clearance is the volume of plasma from which the drug is completely removed per unit time, or, alternatively, the volume of plasma that would have to lose all of the drug that it contains within a unit of time to account for an observed rate of drug elimination.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002758"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002766 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002766">
		<rdfs:label rdf:datatype="&xsd;string">T1/2(in vivo)</rdfs:label>
		<obo:IAO_0000115>The time taken for the concentration of the drug in a particular tissue or blood plasma to decrease by half.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002115"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002768 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002768">
		<rdfs:label rdf:datatype="&xsd;string">T1/2(in vitro)</rdfs:label>
		<obo:IAO_0000115>The time taken for the concentration of the drug in an in-vitro system (e.g., liver microsomes) to decrease by half.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002115"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002771 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002771">
		<rdfs:label rdf:datatype="&xsd;string">AUC(oral)</rdfs:label>
		<obo:IAO_0000115>The area under the drug concentration-time curve following an oral dose.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002120"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002772 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002772">
		<rdfs:label rdf:datatype="&xsd;string">AUC(iv)</rdfs:label>
		<obo:IAO_0000115>The area under the drug concentration-time curve following an intravenous dose.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002120"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002773 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002773">
		<rdfs:label rdf:datatype="&xsd;string">CL(renal)</rdfs:label>
		<obo:IAO_0000115>Clearance of the drug due to renal excretion.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002759"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002774 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002774">
		<rdfs:label rdf:datatype="&xsd;string">CL(hepatic)</rdfs:label>
		<obo:IAO_0000115>Clearance of the drug due to hepatic enzyme activity and biliary excretion.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002759"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002775 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002775">
		<rdfs:label rdf:datatype="&xsd;string">aqueous solubility</rdfs:label>
		<obo:IAO_0000115>The ability of a chemical substance to dissolve in water.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002135"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002801 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002801">
		<rdfs:label rdf:datatype="&xsd;string">fold increase</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000193"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002802 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002802">
		<rdfs:label rdf:datatype="&xsd;string">fold decrease</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000193"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002807 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002807">
		<rdfs:label rdf:datatype="&xsd;string">percent mitotic arrested cells</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0001103"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002808 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002808">
		<rdfs:label rdf:datatype="&xsd;string">permeability</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002128"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002809 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002809">
		<rdfs:label rdf:datatype="&xsd;string">Ka</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000587"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002862 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002862">
		<rdfs:label rdf:datatype="&xsd;string">EC 5 hour</rdfs:label>
		<obo:IAO_0000115>The concentration of compound that elicits an extension of circadian period length by 5 hours.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002877 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002877">
		<rdfs:label rdf:datatype="&xsd;string">AC1000 absolute</rdfs:label>
		<obo:IAO_0000115>The compound concentration at which the fitted curve passes activity threshold 1000.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002878 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002878">
		<rdfs:label rdf:datatype="&xsd;string">AC10 absolute</rdfs:label>
		<obo:IAO_0000115>The compound concentration at which the fitted curve passes activity threshold 10.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002879 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002879">
		<rdfs:label rdf:datatype="&xsd;string">AC26 absolute</rdfs:label>
		<obo:IAO_0000115>The compound concentration at which the fitted curve passes activity threshold 26.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002880 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002880">
		<rdfs:label rdf:datatype="&xsd;string">AC35 absolute</rdfs:label>
		<obo:IAO_0000115>The compound concentration at which the fitted curve passes activity threshold 35.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002881 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002881">
		<rdfs:label rdf:datatype="&xsd;string">AC40 absolute</rdfs:label>
		<obo:IAO_0000115>The compound concentration at which the fitted curve passes activity threshold 40.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002882 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002882">
		<rdfs:label rdf:datatype="&xsd;string">AC500 absolute</rdfs:label>
		<obo:IAO_0000115>The compound concentration at which the fitted curve passes activity threshold 500.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002883 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002883">
		<rdfs:label rdf:datatype="&xsd;string">ECMax</rdfs:label>
		<obo:IAO_0000115>The compound concentration whereupon perceived activity reaches the maximum value observed (with a positive control).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002884 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002884">
		<rdfs:label rdf:datatype="&xsd;string">ECMax_Tm</rdfs:label>
		<obo:IAO_0000115>The compound concentration whereupon perceived activity (change in Tm) reaches the maximum value observed (with a positive control).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002883"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002885 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002885">
		<rdfs:label rdf:datatype="&xsd;string">ECMax_Agonist</rdfs:label>
		<obo:IAO_0000115>The agonist concentration whereupon perceived activity reaches the maximum value observed (with a positive control).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002883"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002886 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002886">
		<rdfs:label rdf:datatype="&xsd;string">ECMax_fold increase</rdfs:label>
		<obo:IAO_0000115>The compound concentration whereupon perceived activity (fold increase) reaches the maximum value observed (with a positive control).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002883"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002887 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002887">
		<rdfs:label rdf:datatype="&xsd;string">ECMax_percent inhibition</rdfs:label>
		<obo:IAO_0000115>The compound concentration whereupon perceived activity (percent inhibition) reaches the maximum value observed (with a positive control).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002883"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002902 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002902">
		<rdfs:label rdf:datatype="&xsd;string">agonism</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000084"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002903 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002903">
		<rdfs:label rdf:datatype="&xsd;string">antagonism</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000084"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002905 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002905">
		<rdfs:label rdf:datatype="&xsd;string">allosteric inhibition</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000091"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002906 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002906">
		<rdfs:label rdf:datatype="&xsd;string">partial activation</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000087"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002907 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002907">
		<rdfs:label rdf:datatype="&xsd;string">allosteric activation</rdfs:label>
		<obo:IAO_0000115>Small molecule that can bind to sites other than the receptor active site and affect activity of the receptor.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000087"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002909 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002909">
		<rdfs:label rdf:datatype="&xsd;string">modulation</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000084"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002910 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002910">
		<rdfs:label rdf:datatype="&xsd;string">allosteric agonism</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002902"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002911 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002911">
		<rdfs:label rdf:datatype="&xsd;string">partial agonism</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002902"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002912 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002912">
		<rdfs:label rdf:datatype="&xsd;string">full agonism</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002902"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002913 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002913">
		<rdfs:label rdf:datatype="&xsd;string">inverse agonism</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002902"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0002914 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0002914">
		<rdfs:label rdf:datatype="&xsd;string">full activation</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000087"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0003035 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0003035">
		<rdfs:label rdf:datatype="&xsd;string">MIC50</rdfs:label>
		<obo:IAO_0000115>The lowest concentration of an antimicrobial agent required to inhibit the growth of 50% of organisms.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0003036 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0003036">
		<rdfs:label rdf:datatype="&xsd;string">ED50</rdfs:label>
		<obo:IAO_0000115>It is the dose that produces an effect in 50% of the tested population, or the dose required to produce half-maximal response.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002116"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0003037 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0003037">
		<rdfs:label rdf:datatype="&xsd;string">Tmax</rdfs:label>
		<obo:IAO_0000115>The time required for a drug to reach maximum concentration in plasma (Cmax) following administration.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002114"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0003038 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0003038">
		<rdfs:label rdf:datatype="&xsd;string">pA2</rdfs:label>
		<obo:IAO_0000115>The negative logarithm (log10) of the molar concentration of antagonist which requires the agonist concentration to be doubled in order to achieve the original response.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0003039 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0003039">
		<rdfs:label rdf:datatype="&xsd;string">IZ</rdfs:label>
		<obo:IAO_0000118>Inhibition zone</obo:IAO_0000118>
		<obo:IAO_0000115>In the disk diffusion susceptibility  test, the zone of inhibition is the clear area surrounding an antimicrobial disk where bacterial growth is inhibited, usually measured as a diameter. The diameter  of  the  zone  of  inhibition  is  proportional  to  the  susceptibility  of  the  organism tested.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002118"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0003040 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0003040">
		<rdfs:label rdf:datatype="&xsd;string">Vd</rdfs:label>
		<obo:IAO_0000118>Volume of distribution</obo:IAO_0000118>
		<obo:IAO_0000115>Volume of Distribution is defined as the theoretical volume in which the total drug administered would need to be distributed to produce the concentration that is observed in plasma. Measured as the total amount of drug in the body divided by the concentration of drug in the plasma.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002758"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0003041 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0003041">
		<rdfs:label rdf:datatype="&xsd;string">Vdss</rdfs:label>
		<obo:IAO_0000118>Volume of distribution at steady state</obo:IAO_0000118>
		<obo:IAO_0000115>The theoretical volume in which the total drug administered would need to be distributed to produce the concentration that is observed in plasma at steady state i.e when the rate of change of amount of drug in the body is zero. VdSS is proportional to the amount of drug in the body versus the plasma concentration of the drug at steady state (pseudo-equilibrium).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002758"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0003042 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0003042">
		<rdfs:label rdf:datatype="&xsd;string">F</rdfs:label>
		<obo:IAO_0000118>BA</obo:IAO_0000118>
		<obo:IAO_0000118>Bioavailability</obo:IAO_0000118>
		<obo:IAO_0000115>Bioavailability is a subcategory of absorption and is the fraction (or %) of unchanged drug that reaches the systemic circulation, thereby accessing the site of action. It is usually determined as the ratio of AUC(oral)/AUC(iv).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002118"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0003115 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0003115">
		<rdfs:label rdf:datatype="&xsd;string">assay endpoint component</rdfs:label>
		<rdfs:label>assay result component</rdfs:label>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0003910 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0003910">
		<rdfs:label rdf:datatype="&xsd;string">allosteric antagonism</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002903"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0010168 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0010168">
		<rdfs:label rdf:datatype="&xsd;string">definitive CYP IC50</rdfs:label>
		<obo:IAO_0000118>definitive CYP IC50</obo:IAO_0000118>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000190"/>
		<bao:submitted_by>SEED Project - Pistoia Alliance</bao:submitted_by>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080001 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080001">
		<rdfs:label rdf:datatype="&xsd;string">IC20</rdfs:label>
		<obo:IAO_0000115>The effective concentration of an inhibitor, which produces 20% of the maximum possible response for that inhibitor.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080002 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080002">
		<rdfs:label rdf:datatype="&xsd;string">IC25</rdfs:label>
		<obo:IAO_0000115>The effective concentration of an inhibitor, which produces 25% of the maximum possible response for that inhibitor.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080003 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080003">
		<rdfs:label rdf:datatype="&xsd;string">IC30</rdfs:label>
		<obo:IAO_0000115>The effective concentration of an inhibitor, which produces 30% of the maximum possible response for that inhibitor.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080004 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080004">
		<rdfs:label rdf:datatype="&xsd;string">phenotypic mode of action</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000074"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080005 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080005">
		<rdfs:label rdf:datatype="&xsd;string">neurite blebbing</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080004"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080006 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080006">
		<rdfs:label rdf:datatype="&xsd;string">neurite branching</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080004"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080007 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080007">
		<rdfs:label rdf:datatype="&xsd;string">neurite outgrowth</rdfs:label>
		<obo:IAO_0000118>neurite elongation</obo:IAO_0000118>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080004"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080008 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080008">
		<rdfs:label rdf:datatype="&xsd;string">neurite shortening</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080004"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080009 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080009">
		<rdfs:label rdf:datatype="&xsd;string">axon bundle defasciculation</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080004"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080010 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080010">
		<rdfs:label rdf:datatype="&xsd;string">axon fasciculation</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080004"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080011 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080011">
		<rdfs:label rdf:datatype="&xsd;string">fragments per kilobase of exon per million mapped reads</rdfs:label>
		<obo:IAO_0000118>FPKM</obo:IAO_0000118>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002138"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080012 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080012">
		<rdfs:label rdf:datatype="&xsd;string">NF-KappaB p65 translocation</rdfs:label>
		<rdfs:comment>need to be reviewed</rdfs:comment>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080004"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080013 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080013">
		<rdfs:label rdf:datatype="&xsd;string">percent neurite outgrowth</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0001103"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080014 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080014">
		<rdfs:label rdf:datatype="&xsd;string">percent neurite count</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0001103"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080015 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080015">
		<rdfs:label rdf:datatype="&xsd;string">percent neurite branch point</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0001103"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080016 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080016">
		<rdfs:label rdf:datatype="&xsd;string">TC50</rdfs:label>
		<obo:IAO_0000119>PubChem AID: 2649</obo:IAO_0000119>
		<obo:IAO_0000116>Date from BAE: 6/22/2016</obo:IAO_0000116>
		<obo:IAO_0000115>The concentration of compound required to kill 50% of a cell population (i.e., 50% inhibitory concentration in a cytotoxicity assay).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080017 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080017">
		<rdfs:label rdf:datatype="&xsd;string">TCID50</rdfs:label>
		<obo:IAO_0000119>PubChem AID: 2024</obo:IAO_0000119>
		<obo:IAO_0000116>Date from BAE: 7/21/2016</obo:IAO_0000116>
		<obo:IAO_0000115>50% Tissue Culture Infective Dose (TCID50) is the measure of infectious virus titer. This endpoint dilution assay quantifies the amount of virus required to kill 50% of infected hosts or to produce a cytopathic effect in 50% of inoculated tissue culture cells.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080018 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080018">
		<rdfs:label rdf:datatype="&xsd;string">reversible inhibition</rdfs:label>
		<obo:IAO_0000119>PubChem AID: 588831</obo:IAO_0000119>
		<obo:IAO_0000116>Date from BAE: 7/19/2016</obo:IAO_0000116>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000091"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080024 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080024">
		<rdfs:label rdf:datatype="&xsd;string">binary endpoint</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080045"/>
		<obo:IAO_0000119>PubChem AID: 449752</obo:IAO_0000119>
		<obo:IAO_0000116>Date from BAE: 5/30/2016</obo:IAO_0000116>
		<obo:IAO_0000115>Any result reported as a simple binary assessment, such as &apos;active/ inactive&apos;, &apos;true/ false&apos;, etc.</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080025 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080025">
		<rdfs:label rdf:datatype="&xsd;string">signal decrease</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000519"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080026 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080026">
		<rdfs:label rdf:datatype="&xsd;string">signal increase</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000519"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080027 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080027">
		<rdfs:label rdf:datatype="&xsd;string">protein level</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002136"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080028 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080028">
		<rdfs:label rdf:datatype="&xsd;string">quantified endpoint</rdfs:label>
		<obo:deprecated>true</obo:deprecated>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080029 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080029">
		<rdfs:label rdf:datatype="&xsd;string">quantified entity</rdfs:label>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080030 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080030">
		<rdfs:label rdf:datatype="&xsd;string">metabaloid profile</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002136"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080031 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080031">
		<rdfs:label rdf:datatype="&xsd;string">Cell Painting Profile</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002136"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080032 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080032">
		<rdfs:label rdf:datatype="&xsd;string">epigenetic profile</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002137"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080033 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080033">
		<rdfs:label rdf:datatype="&xsd;string">cell profile</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002138"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080034 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080034">
		<rdfs:label rdf:datatype="&xsd;string">beta-arrestin clustering assay</rdfs:label>
		<obo:IAO_0000115>The Transfluor assay employs a a beta-arrestin-GFP fusion protein to detect activation of GPCRs: Upon ligand binding the GPCR, cytosolic arrestin-GFP quickly translocates to the cell membrane and then to endocytic vesicles, where it &apos;clusters&apos; and can be detected by fluorescent image analysis. (Developed / commercialized by Norak, then Molecular Devices)</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000110"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080035 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080035">
		<rdfs:label rdf:datatype="&xsd;string">perturbagen / positive control ratio endpoint</rdfs:label>
		<obo:IAO_0000115>The property values are divided by the average value for the positive control wells and multiplied by 100: X&apos; = 100*(X/PosAvg)</obo:IAO_0000115>
		<obo:IAO_0000118>percent postive control</obo:IAO_0000118>
		<obo:IAO_0000118>% positive control</obo:IAO_0000118>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000143"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080036 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080036">
		<rdfs:label rdf:datatype="&xsd;string">Relative Induction Score</rdfs:label>
		<obo:IAO_0000118>RIS</obo:IAO_0000118>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002128"/>
		<bao:submitted_by>SEED Project - Pistoia Alliance</bao:submitted_by>
		<obo:IAO_0000118>Relative Induction Score (RIS)</obo:IAO_0000118>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080037 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080037">
		<rdfs:label rdf:datatype="&xsd;string">Emax</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002118"/>
		<obo:IAO_0000115>Maximum induction effect (dimensionless)</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080038 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080038">
		<rdfs:label rdf:datatype="&xsd;string">molar attenuation coefficient</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002128"/>
		<obo:IAO_0000115>This is a measurement of how strongly a chemical species attenuates light at a given wavelength. Common units are L/(mol*cm).</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080039 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080039">
		<rdfs:label rdf:datatype="&xsd;string">max fold increase</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000193"/>
		<obo:IAO_0000115>The maximum observed fold increase.</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080040 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080040">
		<rdfs:label rdf:datatype="&xsd;string">fraction unbound</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002128"/>
		<obo:IAO_0000115>The fraction of compound that does not bind to substrate (e.x. plasma proteins)</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080041 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080041">
		<rdfs:label rdf:datatype="&xsd;string">cell count</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000583"/>
		<obo:IAO_0000115>Count of cells as an endpoint</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080042 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080042">
		<rdfs:label rdf:datatype="&xsd;string">ratio endpoint</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
		<obo:IAO_0000115>A ratio endpoint is the relative relation between two quantitative results (a/b)</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080043 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080043">
		<rdfs:label rdf:datatype="&xsd;string">blood to plasma ratio</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080042"/>
		<obo:IAO_0000115>The ratio of the concentration of molecule in whole blood (i.e. contains both red blood cells and plasma) to the concentration of molecule in plasma, namely CB/CP.</obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080044 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080044">
		<rdfs:label rdf:datatype="&xsd;string">AC50 Ratio</rdfs:label>
		<obo:IAO_0000115>Ratio of AC50 values</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080042"/>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002162"/>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080045 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080045">
		<rdfs:label rdf:datatype="&xsd;string">categorical endpoint</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
		<obo:IAO_0000115>A categorical endpoint is any result that can take one of a limited number of possible values. </obo:IAO_0000115>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080046 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080046">
		<rdfs:label rdf:datatype="&xsd;string">electrical endpoint</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
		<obo:IAO_0000115>Branch of endpoints reported by electrical measurements.</obo:IAO_0000115>
		<bao:submitted_by>https://github.com/Scientist328455 https://github.com/BioAssayOntology/BAO/issues/62</bao:submitted_by>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080047 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080047">
		<rdfs:label rdf:datatype="&xsd;string">electrical current density</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080046"/>
		<obo:IAO_0000115>Electrical current density is a measure of the density of flow of electric charge; it is the electric current per unit area of cross section. Electric current density is a vector-valued quantity.</obo:IAO_0000115>
		<bao:hasXref>https://qudt.org/vocab/quantitykind/ElectricCurrentDensity</bao:hasXref>
		<bao:submitted_by>https://github.com/Scientist328455 https://github.com/BioAssayOntology/BAO/issues/62</bao:submitted_by>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080048 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080048">
		<rdfs:label rdf:datatype="&xsd;string">fraction metabolised</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0002128"/>
		<obo:IAO_0000115>The fraction of the bioavailable dose which has been metabolized.</obo:IAO_0000115>
		<bao:hasXref>http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C184704</bao:hasXref>
		<bao:submitted_by>SEED Project - Pistoia Alliance</bao:submitted_by>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080049 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080049">
		<rdfs:label rdf:datatype="&xsd;string">Kp</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080042"/>
		<obo:IAO_0000115>Kp values are defined as the ratio of total concentration of compound in the tissue to total concentration of compound in the plasma at steady state.</obo:IAO_0000115>
		<bao:hasXref>https://github.com/BioAssayOntology/BAO/issues/103</bao:hasXref>
		<bao:submitted_by>https://github.com/Scientist328455</bao:submitted_by>
		<obo:IAO_0000118>tissue-to-plasma concentration ratio</obo:IAO_0000118>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080050 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080050">
		<rdfs:label rdf:datatype="&xsd;string">kobs</rdfs:label>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000487"/>
		<obo:IAO_0000115>observed rate constant</obo:IAO_0000115>
		<bao:submitted_by>https://github.com/Scientist328455</bao:submitted_by>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080051 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080051">
		<rdfs:label rdf:datatype="&xsd;string">physiological endpoint</rdfs:label>
		<obo:IAO_0000115>A physiological endpoint is a response from either an isolated tissue or organ (i.e. smooth muscle contraction, urine output ) that also serves as an observed enpoint for a bioassay.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0000179"/>
		<bao:submitted_by>Opioid Drug Ontology (ODO) (https://opioiddrugontology.github.io/) - Nicolette Ross (https://orcid.org/0000-0002-4677-2140)</bao:submitted_by>
		<obo:IAO_0000116>[DefinitionUpdate: BAO v 2.8.15 (May 2025)] [NodeCreation: BAO v 2.8.13 (March 2025)]</obo:IAO_0000116>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080052 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080052">
		<rdfs:label rdf:datatype="&xsd;string">urine output</rdfs:label>
		<obo:IAO_0000115>The amount of urine excreted.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080051"/>
		<bao:submitted_by>Opioid Drug Ontology (ODO) (https://opioiddrugontology.github.io/) - Nicolette Ross (https://orcid.org/0000-0002-4677-2140)</bao:submitted_by>
		<obo:IAO_0000116>[DefinitionUpdate: BAO v 2.8.15 (May 2025)] [NodeCreation: BAO v 2.8.13 (March 2025)]</obo:IAO_0000116>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080053 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080053">
		<rdfs:label rdf:datatype="&xsd;string">relative bias</rdfs:label>
		<obo:IAO_0000115>Ratio of functional bias calculated for a test agonist compound/the measured functional bias of a reference agonist compound allowing for normalization within a single assay (parameter: ΔLog τ/KA).</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080042"/>
		<bao:submitted_by>Opioid Drug Ontology (ODO) (https://opioiddrugontology.github.io/) - Nicolette Ross (https://orcid.org/0000-0002-4677-2140)</bao:submitted_by>
		<obo:IAO_0000116>[DefinitionUpdate: BAO v 2.8.15 (May 2025)] [NodeCreation: BAO v 2.8.13 (March 2025)]</obo:IAO_0000116>
	</owl:Class>

	<!-- http://www.bioassayontology.org/bao#BAO_0080054 -->

	<owl:Class rdf:about="http://www.bioassayontology.org/bao#BAO_0080054">
		<rdfs:label rdf:datatype="&xsd;string">bias factor</rdfs:label>
		<obo:IAO_0000115>The bias factor, defined as 10ˆΔΔLogτ/KA(assay1-assay2), quantifies the difference in relative agonist activity between two assays. A higher bias factor indicates a greater distinction in the agonist&apos;s performance across the two assays relative to the reference agonist.</obo:IAO_0000115>
		<rdfs:subClassOf rdf:resource="http://www.bioassayontology.org/bao#BAO_0080042"/>
		<bao:submitted_by>Opioid Drug Ontology (ODO) (https://opioiddrugontology.github.io/) - Nicolette Ross (https://orcid.org/0000-0002-4677-2140)</bao:submitted_by>
		<obo:IAO_0000119>https://doi.org/10.1016/j.cell.2017.10.035</obo:IAO_0000119>
		<obo:IAO_0000116>[DefinitionUpdate: BAO v 2.8.15 (May 2025)] [NodeCreation: BAO v 2.8.13 (March 2025)]</obo:IAO_0000116>
	</owl:Class>

</rdf:RDF>